Focused Wealth Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-7
| Closed | – | – | 735 |
|
|
2019
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 703 |
|
|
2018
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 705 |
|
|
2018
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 663 |
|
|
2018
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 685 |
|
|
2018
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 705 |
|
|
2017
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 702 |
|
|
2017
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 680 |
|
|
2017
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 710 |
|
|
2016
Q4 | – | Sell |
-7
| Closed | – | – | 714 |
|
|
2016
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 686 |
|
|
2016
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 693 |
|
|
2016
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 683 |
|
|
2015
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 693 |
|
|
2015
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 690 |
|
|
2015
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 674 |
|
|
2015
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 686 |
|
|
2014
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 674 |
|
|
2014
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 679 |
|
|
2014
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 664 |
|